ARRZX | VMVAX | ARRZX / VMVAX | |
Total Expense Ratio | 0.78 | 0.07 | 1,114% |
Annual Report Gross Expense Ratio | 0.98 | 0.07 | 1,400% |
Fund Existence | 8 years | 14 years | - |
Gain YTD | 4.074 | -1.539 | -265% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 3000 | 166,667% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 49.3M | 29.1B | 0% |
Annual Yield % from dividends | 1.01 | 2.40 | 42% |
Returns for 1 year | -0.17 | 3.63 | -5% |
Returns for 3 years | 15.50 | 15.72 | 99% |
Returns for 5 years | 50.11 | 76.66 | 65% |
Returns for 10 years | N/A | 75.91 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DRIV | 21.52 | 0.22 | +1.03% |
Global X Atnms & Elctrc Vhcls ETF | |||
DFIV | 40.77 | 0.35 | +0.87% |
Dimensional International Value ETF | |||
FTDS | 50.34 | N/A | N/A |
First Trust Dividend Strength ETF | |||
SCO | 20.62 | -0.45 | -2.14% |
ProShares UltraShort Bloomberg Crude Oil | |||
ARKG | 21.13 | -0.60 | -2.76% |
ARK Genomic Revolution ETF |